Effectiveness of Two and Three Doses of COVID-19 mRNA Vaccines Against Infection, Symptoms, and Severity in the Pre-Omicron Era: A Time-Dependent Gradient

April 14, 2024

Vaccine

This article aims to characterize patterns in the protection provided by the BNT162b2 and mRNA-1273 vaccines against a spectrum of SARS-CoV-2 infection symptoms and severities.

Journal Article

Archived File

Access from source

Effectiveness of Two and Three Doses of COVID-19 mRNA Vaccines Against Infection, Symptoms, and Severity in the Pre-Omicron Era: A Time-Dependent Gradient

Recent Posts

Archives

Categories